Britain approves AstraZeneca's preventative COVID therapy - SABC News - Breaking news, special reports, world, business, sport coverage of all South African current events. Africa's news leader.

  • 📰 SABCNews
  • ⏱ Reading Time:
  • 32 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 16%
  • Publisher: 51%

Malaysia News News

Malaysia Malaysia Latest News,Malaysia Malaysia Headlines

Britain’s medicines regulator has approved AstraZeneca’s antibody-based COVID-19 treatment for preventing infections in adults with poor immune response, marking a major step in the fight against the pandemic as infections surge globally. COVID19

A test tube labelled with the vaccine is seen in front of AstraZeneca logo in this illustration taken, September 9, 2020.A test tube labelled with the vaccine is seen in front of AstraZeneca logo in this illustration taken, September 9, 2020.

Figures showing a global rise in COVID-19 cases could herald a much bigger problem, the World Health Organization said this week, warning nations to remain vigilant. Vaccines rely on an intact immune system to develop targeted antibodies and infection-fighting cells, but Evusheld contains lab-made antibodies designed to linger in the body for months to contain the virus in case of an infection.

Evusheld is under a European review and has been authorised in the United States to prevent COVID-19 infections in individuals with weak immune systems or a history of severe side effects from coronavirus vaccines.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

What about side effects, vaccinate at your own risk'

🤫

Asikhathali noma ngabe u Jesu uqobo lwakhe othi asijove ngomchamo wenja okusalayo asijovi so stop trying 🙄

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 37. in MY

Malaysia Malaysia Latest News, Malaysia Malaysia Headlines